Zhong Ji Longevity Science Group (HKG:0767) agreed to acquire 25% interest in Asian Integrated Cell Laboratory from China International Osteoarticular Medical Group for an initial consideration of HK$300 million, a Monday Hong Kong bourse filing said.

Shares of the longevity firm were up nearly 4% in Tuesday afternoon trading.

The consideration for the deal will be satisfied through the issue of non-redeemable convertible bonds.

The bonds will carry no interest rate and will be convertible into a maximum of 545.5 million shares at HK$0.55 apiece.

The target firm operates boutique high-end customized stem cells and IPSC storage center with testing and preclinical immunotherapies services.